Walnut Physician Dejun Wang Indicted: Accused of Selling Ozempic and Other Drug Samples to San Gabriel Valley Pharmacies
Los Angeles: The U.S. Attorney's Office for the Central District of California announced on October 22 that Dejun Wang, 62, of Walnut, a physician, has been indicted by a federal grand jury for the prohibited sale of prescription drug samples. Prosecutors allege Wang sold sample drugs, including Rybelsus, Ozempic and Mounjaro, to the owners of pharmacies in the San Gabriel Valley, who repackaged and dispensed them to customers. The Justice Department notes that drug samples are prescription drugs provided to promote a drug's sale and are not intended to be sold.
The case is being investigated by the FBI and the U.S. Department of Health and Human Services Office of Inspector General (HHS-OIG), and is prosecuted by Assistant U.S. Attorney Sebastian Bellm. Wang's case is part of a major health care fraud takedown the Justice Department announced in Los Angeles the same day, charging 15 defendants, including six medical professionals, in schemes that collectively resulted in about $2 billion in fraudulent claims, including more than $1.6 billion billed for sham substance abuse treatment that lured vulnerable people to Southern California, and $134 million billed to Medicare for unnecessary arterial procedures. Eight defendants were arrested that day.
The Justice Department emphasizes that an indictment merely contains allegations and that all defendants are presumed innocent until proven guilty beyond a reasonable doubt. Prosecutors have not announced Wang's potential penalties or court schedule.
Source: GSM · USA (original Chinese edition)
Photo: 图：位于洛杉矶市中心的第一街美国联邦法院大楼外立面（资料图）。Levi Clancy摄，CC0，经维基共享资源。Photo: The First Street U.S. Courthouse in downtown Los Angeles (file photo), by Levi Clancy, CC0, via Wikimedia Commons.
- 2026-10-22Walnut Physician Dejun Wang Indicted: Accused of Selling Ozempic and Other Drug Samples to San Gabriel Valley PharmaciesThis story
- 2026-10-22DOJ Charges 15 in Los Angeles Health Care Fraud Takedown Tied to Over $1.8 Billion in Alleged False Claims
